DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,038 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $10,793,710 | +1.8% | 43,200 | +1.7% | 0.07% | -5.3% |
Q1 2024 | $10,604,713 | +13.5% | 42,467 | +5.2% | 0.08% | +4.1% |
Q4 2023 | $9,341,898 | -5.4% | 40,382 | -26.1% | 0.07% | -17.0% |
Q3 2023 | $9,874,088 | +8.8% | 54,649 | +49.4% | 0.09% | +11.4% |
Q2 2023 | $9,075,654 | -4.2% | 36,579 | -2.7% | 0.08% | -12.2% |
Q1 2023 | $9,472,921 | +66.2% | 37,585 | -13.0% | 0.09% | -68.6% |
Q4 2022 | $5,700,966 | -46.3% | 43,222 | +5.2% | 0.29% | +135.2% |
Q3 2022 | $10,615,000 | -47.0% | 41,097 | -48.0% | 0.12% | -31.8% |
Q2 2022 | $20,041,000 | -5.1% | 79,050 | +9.8% | 0.18% | +10.5% |
Q1 2022 | $21,128,000 | -14.7% | 72,027 | -4.3% | 0.16% | -12.9% |
Q4 2021 | $24,770,000 | -30.8% | 75,288 | -35.9% | 0.19% | -18.1% |
Q3 2021 | $35,776,000 | +154.7% | 117,510 | +124.5% | 0.23% | +84.6% |
Q2 2021 | $14,044,000 | +39.1% | 52,333 | +16.7% | 0.12% | +28.1% |
Q1 2021 | $10,096,000 | +8.7% | 44,854 | +7.3% | 0.10% | -1.0% |
Q4 2020 | $9,288,000 | +45.4% | 41,810 | +32.9% | 0.10% | +16.9% |
Q3 2020 | $6,390,000 | +28.1% | 31,460 | +11.5% | 0.08% | +20.3% |
Q2 2020 | $4,987,000 | +193.0% | 28,203 | +129.3% | 0.07% | +122.6% |
Q1 2020 | $1,702,000 | -19.4% | 12,300 | -10.6% | 0.03% | -6.1% |
Q4 2019 | $2,112,000 | -15.6% | 13,764 | -21.6% | 0.03% | -15.4% |
Q3 2019 | $2,501,000 | +39.5% | 17,562 | +40.0% | 0.04% | +21.9% |
Q2 2019 | $1,793,000 | -9.3% | 12,548 | -16.2% | 0.03% | -17.9% |
Q1 2019 | $1,976,000 | +85.0% | 14,975 | +44.5% | 0.04% | +50.0% |
Q4 2018 | $1,068,000 | -29.6% | 10,363 | -25.8% | 0.03% | -16.1% |
Q3 2018 | $1,517,000 | +50.8% | 13,964 | +36.4% | 0.03% | +82.4% |
Q2 2018 | $1,006,000 | +131.3% | 10,240 | +131.1% | 0.02% | 0.0% |
Q1 2018 | $435,000 | -66.7% | 4,431 | -67.7% | 0.02% | -69.1% |
Q4 2017 | $1,305,000 | -20.4% | 13,721 | -27.2% | 0.06% | +34.1% |
Q3 2017 | $1,640,000 | +5.0% | 18,852 | -0.3% | 0.04% | -2.4% |
Q2 2017 | $1,562,000 | +1.5% | 18,917 | +5.4% | 0.04% | -2.3% |
Q1 2017 | $1,539,000 | +8.6% | 17,946 | +3.0% | 0.04% | -6.5% |
Q4 2016 | $1,417,000 | +211.4% | 17,421 | +197.6% | 0.05% | +142.1% |
Q3 2016 | $455,000 | -30.3% | 5,854 | -27.6% | 0.02% | -26.9% |
Q2 2016 | $653,000 | +40.7% | 8,081 | +60.1% | 0.03% | +18.2% |
Q1 2016 | $464,000 | -21.1% | 5,047 | -20.2% | 0.02% | -21.4% |
Q4 2015 | $588,000 | +3.7% | 6,326 | -4.9% | 0.03% | -9.7% |
Q3 2015 | $567,000 | -9.1% | 6,655 | -8.8% | 0.03% | +3.3% |
Q2 2015 | $624,000 | +13.9% | 7,296 | +13.0% | 0.03% | -6.2% |
Q1 2015 | $548,000 | -60.4% | 6,458 | -60.0% | 0.03% | -64.0% |
Q4 2014 | $1,385,000 | -2.5% | 16,156 | -13.6% | 0.09% | -9.2% |
Q3 2014 | $1,420,000 | +14.2% | 18,691 | +18.4% | 0.10% | -8.4% |
Q2 2014 | $1,243,000 | +379.9% | 15,784 | +357.8% | 0.11% | +296.3% |
Q1 2014 | $259,000 | -85.8% | 3,448 | -85.4% | 0.03% | -86.7% |
Q4 2013 | $1,821,000 | – | 23,590 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |